SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0685-2.1%3:39 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Mammon5/30/2014 9:15:13 AM
1 Recommendation

Recommended By
SG

  Read Replies (1) of 13111
 
What do you all think the company should do now?
Another short study with pain as an endpoint?
A phase III with non injected lesion ablation as an endpoint?
Sell to a big pharma and let them figure it out?
Concentrate on liver or other indications?
Quickly do a regional deal to reestablish credibility? Half my relatives now think I invested for 7 years in a scam stock. I am not happy. I worry that the management will just continue to accrue large salaries and raise more money while doing a pain study that leads nowhere. I think that they should drop their salaries to $1 until they show some visible [regional deal, etc] sign of corporate success.
[Yep, I said something negative about pvct! ]
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News